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Abstract  
Blue light sensitivity of melatonin suppression and subjective mood and alertness responses in 
humans is recognised as being melanopsin based. Observations that long wavelength (red) light 
can potentiate responses to subsequent short wavelength (blue) light have been attributed to the 
bistable nature of melanopsin whereby it forms stable associations with both 11-cis and all-
trans isoforms of retinaldehyde and uses light to transition between these states. The current 
study examined the effect of concurrent administration of blue and red monochromatic light, as 
would occur in real-world white light, on acute melatonin suppression and subjective mood and 
alertness responses in humans. Young healthy males (18-35 years; n = 21) were studied in 
highly controlled laboratory sessions that included an individually timed 30 min light stimulus 
of blue (λmax 479 nm) or red (λmax 627 nm) monochromatic light at varying intensities (1013 - 
1014 photons/cm2/s) presented, either alone or in combination, in a within-subject randomised 
design. Plasma melatonin levels and subjective mood and alertness were assessed at regular 
intervals relative to the light stimulus. Subjective alertness levels were elevated after light onset 
irrespective of light wavelength or irradiance. For melatonin suppression, a significant 
irradiance response was observed with blue light. Co-administration of red light, at any of the 
irradiances tested, did not significantly alter the response to blue light alone. Under the current 
experimental conditions the primary determinant of the melatonin suppression response was 
the irradiance of blue 479 nm light and this was unaffected by simultaneous red light 
administration. 
Keywords  
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Introduction 
Ocular light exposure in mammals can generate a range of acute non-visual physiological and 
behavioural responses, which are maximally sensitive to short wavelength blue light (λmax ~ 
480 nm). In humans these include suppression of the nocturnal pineal hormone melatonin 
(Brainard et al. 2001; Thapan et al. 2001), circadian phase shifting (Lockley et al. 2003; Sletten 
et al. 2009), and enhancement of mood, alertness, and performance (Lockley et al. 2006; Revell 
et al. 2006). This blue light sensitivity in humans (λmax 440 - 480 nm) is attributed to the 
photopigment melanopsin expressed in the inner retina in a subset of intrinsically 
photosensitive retinal ganglion cells (ipRGCs) (Berson et al. 2002; Gooley et al. 2001), which 
innervate brain areas regulating these non-visual responses (Gooley et al. 2003; Hattar et al. 
2006). In addition, the ipRGCs receive photic input from the rod and cone visual 
photoreceptors which contribute to non-visual responses in a context dependent manner 
(Altimus et al. 2010; Lall et al. 2010). 
Melanopsin is an atypical vertebrate opsin, being most homologous to invertebrate 
rhabdomeric opsins (Provencio et al. 2000), and having a sluggish, yet sustained, response to 
light (Berson et al. 2002; Dacey et al. 2005). Furthermore, through studies of human 
melanopsin (Melyan et al. 2005) and the Amphioxus homolog (Koyanagi et al. 2005) it has 
been suggested that melanopsin exhibits bistable properties and forms stable associations with 
both 11-cis (R, rhodopsin) and all-trans (M, metarhodopsin) isoforms of retinaldehyde, 
existing in equilibrium between these two states, with light driving their interconversion.  The 
existence of such an intrinsic photoisomerase function to regenerate the chromophore 
(conversion of M to R state), removes the physical reliance on an external regeneration 
mechanism such as the retinal pigment epithelium. Whilst heterologous expression studies 
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have indicated that the photosensitivity function (R to M state) is blue light sensitive (420 - 480 
nm) (Panda et al. 2005), the photoisomerase function (M to R state) is purported to be long 
wavelength shifted (Melyan et al. 2005).  This proposed sensitivity is supported by 
observations, in both murine suprachiasmatic nuclei single cell recordings (Mure et al. 2007) 
and the human pupillary constriction response (Mure et al. 2009), where pre-treatment with 
long wavelength light (λmax 620 nm) potentiated responses to subsequent blue light stimuli, 
presumably by increasing the available pool of the R state. Not all studies, however, have been 
able to demonstrate such potentiation (Mawad and Van Gelder 2008) and the existence and 
physiological significance of melanopsin bistability remains an area of controversy. In addition 
to the potential existence of a long wavelength sensitive melanopsin photoisomerase function, 
it is also suggested that the medium and long wavelength sensitive cone photoreceptors can 
contribute to human non-visual light responses (Gooley et al. 2010). Combined, these 
observations suggest that the long wavelength content of a polychromatic light pulse may be an 
important factor for driving non-visual responses to light. 
In the real world it is likely that the proposed photosensitivity and photoisomerase 
functions of melanopsin will be stimulated simultaneously by short and long wavelength light, 
under both broadband polychromatic white lights and natural lighting (400 – 700 nm). This is 
different to the consecutive presentation of short and long wavelengths of light that has been 
used in the previous in vivo studies (Mure et al. 2009; Mure et al. 2007). If melanopsin 
bistability is to be of practical use then it is essential that the response to concurrent blue and 
red light is assessed. Therefore, in the current study, we aimed to determine whether the acute 
suppression of melatonin and elevation of mood and alertness by short wavelength blue light 
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(λmax 479 nm) could be altered (enhanced or reduced) by simultaneous presentation of long 
wavelength red (λmax 627 nm) light. 
Materials and Methods 
All procedures were approved by the University of Surrey Ethics Committee and were 
conducted in accordance with the Declaration of Helsinki and conformed to international 
ethical standards. Participants gave written consent.  
Participants. Healthy males (n = 21) aged 18-35 yrs (22.8 ± 3.5 years; mean ± SD) 
participated. As assessed by self-completed questionnaires, subjects were drug and prescription 
medication free, non-smokers and with no reported medical or psychological conditions. 
Participants had not crossed more than two time-zones and/or worked night shifts during the 
month before the study. They had regular sleep-wake cycles with no reported sleep disorders 
(Pittsburgh Sleep Quality Index ≤ 5), and were neither extreme morning nor evening types 
(Horne-Östberg Morningness Eveningness Questionnaire score: 51.6 ± 6.6; mean ± SD). A full 
ophthalmic examination was performed on all participants to confirm they were free from any 
ocular disorders including colour vision deficiencies according to the Ishihara colour blindness 
plate test.  
Pre-study measurements. The protocol used was similar to that previously described 
(Revell and Skene 2007) with participants maintaining a regular, actigraphically (AWL, 
Cambridge Neurotechnology, UK) monitored sleep/wake schedule for at least 7 days before 
and throughout the in-laboratory sessions. For 72 h before each laboratory session and for its 
duration, participants refrained from caffeinated drinks, alcohol, excessive exercise, bright 
lights and non-steroidal anti-inflammatory drug intake. In addition, subjects performed a 48 h 
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urine collection (sequential 4 h collection bins, 8 h overnight) for measurement, via 
radioimmunoassay, of 6-sulphatoxymelatonin, the major urinary metabolite of melatonin 
(Stockgrand Ltd., University of Surrey, Guildford, UK). The acrophase of 6-
sulphatoxymelatonin production was determined by cosinor analysis enabling light 
administration to be individually timed to occur on the rising phase of each participant’s 
endogenous melatonin rhythm. 
In-laboratory protocol. Details of the protocol were previously described (Revell and 
Skene 2007). A randomised, within-subject, cross-over design was utilised. Participants were 
assigned to one of two study protocols which differed only in the light conditions administered 
(Study A: 8 overnight sessions, n = 10; Study B: 6 overnight sessions, n = 11). The sessions 
were run in blocks of three or four consecutive nights, which were separated by at least three 
days. The overnight in-laboratory sessions (1900 - 0700 h; Oct – Apr, 2008- 2010) contained a 
2 h experimental period between 2300 and 0300 h. Night one was always a control condition 
(no light) and the subsequent light exposures were randomised across the remaining sessions. 
Throughout each study session posture, environmental lighting and meals were strictly 
controlled.  
The participants’ pupils were fully dilated by a single drop of Minims Tropicamide 
(1.0%) (Chauvin Pharmaceuticals, Romford, UK) placed in each eye 90 min before the light 
exposure. Blood samples were taken at regular 15 min intervals relative to the light exposure 
from 30 min before to up to 90 min after the start of the light pulse. The plasma fraction from 
each sample was stored at –20 C until melatonin analysis by radioimmunoassay. In addition, 
verbal ratings of subjective sleepiness (Karolinska Sleepiness Scale (KSS) (Akerstedt and 
Gillberg 1990) and mood and alertness (four 9-point scales: alertness, cheerfulness, depression, 
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calmness (Revell et al. 2006) were obtained at 15 min intervals from 15 min before until 45 
min after the start of the light exposure.  
Light exposure. As previously described (Revell et al. 2010) the 30 min light pulse was 
administered using a specially constructed 45 cm diameter sphere (Apollo Lighting, Leeds, 
UK). The sphere was coated with white reflectance paint (WRC-680 Labsphere, Pro-Lite 
Technology, Bedfordshire, UK) and was illuminated via a fibre optic cable connected to an 
ultra high-pressure mercury lamp (Focus 100LS3, 100 W, Philips Lighting, Eindhoven, The 
Netherlands) to provide patternless illumination encompassing the entire visual field. 
Monochromatic light was produced using narrow bandwidth interference filters (Coherent 
Ealing Europe Ltd., Watford, UK) with λmax 480 and 630 nm (half maximal bandwidth λ0.5 10 
nm). The actual in situ λmax at eye level was shifted to 479 and 627 nm, respectively as 
measured by a calibrated spectrometer (Ocean Optics BV, Dunedin, Florida, USA). Light 
irradiances were adjusted using neutral density filters (Kodak, Hemel Hempsted, UK) and were 
verified at the subject’s eye level using a calibrated radiometer (R203, Macam Photometrics 
Ltd., Livingston, Scotland) before and after each light exposure. Head movements and gaze 
were restricted and subjects were monitored by trained researchers throughout the light 
stimulus. 
Short wavelength blue (λmax 479 nm) and long wavelength red (λmax 627 nm) 
monochromatic lights were administered alone or in combination at a range of photon densities 
(Table 1). The photon densities were selected on the basis of previously determined irradiance 
response curves to monochromatic light for melatonin suppression (Thapan et al. 2001) and the 
reported spectral responses of the human pupil light reflex (Mure et al. 2009), to be within the 
melanopsin operating range and to ensure that either a potentiation or a reduction in the 
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response could be observed. The highest irradiance of red monochromatic light tested was 
matched to that previously shown to be effective at enhancing subsequent pupil constriction 
responses to blue light (Mure et al. 2009). In Study A, three irradiances of 479 nm light (1013-
1014 photons/cm2/s) were administered with and without a fixed irradiance (5 x 1013 
photons/cm2/s) of 627 nm light (n = 10). A subset of participants received 627 nm light alone at 
either 5 x 1013 photons/cm2/s (n = 5) or 1 x 1014 photons/cm2/s (n = 4). In Study B, a fixed 
irradiance of 479 nm light (2.5 x 1013 photons/cm2/s) was administered alone and with varying 
irradiances of 627 nm light (1013 - 1014 photons/cm2/s) (n = 11).  A subset of participants 
received 627 nm light alone at 3 x 1014 photons/cm2/s (n = 8). 
Analysis and statistics. Plasma was separated within 10 minutes of collection by 
refrigerated centrifugation (3000 rpm for 10 min) and stored at -20 C until analysis. Plasma 
melatonin was assayed by radioimmunoassay (affinity stripped plasma and anti-melatonin 
antiserum G/S/704-8483, Stockgrand Ltd., University of Surrey, Guildford, UK; tritiated 
melatonin TRK-798, Amersham International Ltd., Buckinghamshire, UK) (Fraser et al. 1983). 
The limit of detection was 6 pg/ml and the inter-assay coefficients of variation were 16% at 25 
pg/ml, 8% at 89 pg/ml and 8% at 112 pg/ml (n = 26 for each concentration). Melatonin profiles 
suitable for analysis were obtained from 20 of the 21 participants (Study A, n = 10; Study B, n 
= 10). Percentage melatonin suppression was calculated as the change in melatonin levels from 
0 to 30 min as a percentage of the 0 min levels (Revell et al. 2010). Mood and alertness scores 
at each time point (-15, 0, 15, 30 and 45 min) were expressed relative to an individual’s score 
at 0 min for each light condition. For clarity, the alertness, cheerfulness, and calmness ratings 
were reverse-scored such that a higher rating indicated increased mood and alertness. All 
statistical analysis was carried out using SPSS 16.0 (SPSS Inc., Chicago, IL, USA). The 
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significance level was set at p ≤ 0.05 and significant results were compared post-hoc by 
Bonferroni test. For melatonin raw data paired Student’s t-test was used to compare pre-
exposure (0 min) and post-exposure (30 min) plasma melatonin concentrations separately for 
each light condition.  In addition, repeated measures ANOVA was used to compare the 0 min 
plasma melatonin concentration between light conditions. For the remaining analysis repeated 
measures ANOVA were used with the following factors: Melatonin suppression: 1) 479 nm vs. 
627 nm, wavelength and time; 2) Study A, red light presence and blue light irradiance; 3) 
Study B red light irradiance. For mood and alertness: Study A, red light presence, blue light 
irradiance and time; Study B, red light irradiance and time. 
Results 
The ability of blue (λmax 479 nm) and red (λmax 627 nm) monochromatic light, of varying 
photon densities presented alone and in combination, to influence plasma melatonin levels and 
subjective mood and alertness was quantified in healthy male participants. 
Minimal suppression of melatonin range (-2.9% to 16.7%; n = 17) was observed during 
the administration of 627 nm light alone at all photon densities tested (5 x 1013 – 3 x 1014 
photons/cm2/s). At all photon densities, the observed melatonin suppression with 627 nm light 
did not significantly differ from that of the “no-light” baseline condition as demonstrated by 
within-subject comparisons (data not shown).  Representative plasma melatonin profiles (raw 
data) from three participants receiving the ‘no-light’ control as well as 627nm, 479 nm, and 
479 + 627 nm light at varying irradiances are shown in Figure 1.  
Blue (479 nm) light produced significantly greater melatonin suppression than photon 
matched red (627 nm) light as evidenced by within-subject comparisons at 5 x 1013 and 1 x 
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1014 photons/cm2/s,  Figure 2A (F (1, 4) = 14.9, p = 0.018, n = 5) and Figure 2B (F (1, 3) = 25.7, p 
= 0.015, n = 4) respectively. Furthermore, the lowest irradiance 479 nm light (2.5 x 1013 
photons/cm2/s) was significantly more effective at suppressing melatonin than a 12-fold 
brighter 627 nm light pulse (3 x 1014 photons/cm2/s) (Figure 2C; F (1, 7) = 11.4, p = 0.012; n = 
8).  
Melatonin suppression was calculated by comparing the plasma melatonin levels before 
(0 min) and at the end (30 min) of the light stimulus.  For each study, the levels at 0 min did 
not differ significantly between light conditions (including the no light control) (Study A: 56.7 
– 64.0 pg/ml, mean range; 59.4 ± 5.6 pg/ml, mean ± SEM; F (6, 54) = 0.8, p = 0.489, n = 10.  
Study B: 65.3 - 74.8 pg/ml; 70.1 ± 3.5 pg/ml; F (4, 36) = 2.4, p = 0.066, n = 10).  At 30 min, 
under the baseline ‘no-light’ condition plasma melatonin levels were significantly elevated ( p 
< 0.05) whereas under 479 nm light at 5 x 1013 and 1 x 1014 photons/cm2/s melatonin levels 
were significantly suppressed ( p < 0.01) (Figure 3). 
In Study A, irradiance dependency of melatonin suppression was observed for both 479 
nm light alone and 479 + 627 nm light pulses (Figure 4A; F (2, 18) = 17.3, p < 0.001). However, 
no significant effects of red light presence (479 nm alone vs. 479 + 627 nm) or red light 
presence*blue light irradiance interaction were observed.  Similarly, in Study B the melatonin 
suppression observed with 479 nm light alone (2.5 x 1013 photons/cm2/s) did not differ 
significantly to that obtained with bichromatic pulses containing 479 nm light and increasing 
irradiances of 627 nm light (Figure 4B; F (3, 27) = 2.1, p = 0.122).  
At lower photon densities (5 x 1013 photons/cm2/s) 479 nm light significantly (p = 
0.049) enhanced subjective alertness ratings compared to 627 nm light as demonstrated by 
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within-subject comparisons (data not shown). In Study A, there was a significant effect of time 
on subjective alertness (F (4, 36) = 3.3, p = 0.020) (Figure 5A) and sleepiness (F (4, 36) = 3.3, p = 
0.022) but no significant effect of light condition or light condition*time interaction. A 
significant light condition*time interaction for depression was revealed (F (4, 36) = 2.9, p = 
0.035).  In Study B a significant effect of time was observed for alertness (F (4, 40) = 7.9, p = 
0.003) (Figure 5B), calmness (F (4, 40) = 8.8, p < 0.001), depression (F (4, 40) = 5.1, p = 0.002), 
and sleepiness (F (4, 40) = 6.1, p = 0.006) levels but no significant effect of light condition or 
light condition*time interaction. 
Discussion 
The current study aimed to test the hypothesis that acute melatonin and subjective measures of 
alertness and mood to short wavelength blue light (λmax 479 nm) could be significantly altered 
by concurrent presentation of long wavelength red light (λmax 627 nm).  
In accordance with previous studies of light-induced melatonin suppression (Brainard et 
al. 2001; Thapan et al. 2001), we observed a clear irradiance dependency with blue 
monochromatic light. In addition, minimal melatonin suppression (non control-adjusted) was 
observed with red monochromatic light. This is in agreement with a previous study (Hanifin et 
al. 2006) where a 90 min red monochromatic light stimulus (1.9  x 1018 photons/cm2), over 
6000 times brighter than our highest photon density red light, only induced 18% melatonin 
suppression (control adjusted) that did not significantly differ from the ‘no-light’ control 
response (Hanifin et al. 2006).   
The current study demonstrates for the first time that simultaneous presentation of red 
627 nm light neither enhanced nor reduced the degree of melatonin suppression observed with 
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blue 479 nm light alone. This was true when a fixed irradiance red light pulse (5 x 1013 
photons/cm2/sec) was added to increasing irradiances of blue light (Study A) and when a fixed 
irradiance blue light pulse (2.5 x 1013 photons/cm2/sec) was administered with increasing 
irradiances of red light (Study B).  At lower irradiances (5 x 1013 photons/cm2/s) 479 nm light 
was more effective at enhancing subjective alertness levels than photon matched 627 nm light. 
The lack of this discrepancy at higher irradiances suggests that at these levels either the 
irradiance of the light is more determinative than wavelength for alertness or that the subjective 
scales lack sufficient resolution at higher photon densities. Similar to the melatonin suppression 
data, the addition of a fixed irradiance red light did not enhance the alerting response to blue 
light alone. The observed photic enhancement of subjective mood and alertness at night, 
irrespective of light irradiance and composition, in dark adapted individuals is in accordance 
with our previous data (Revell et al. 2010).  
 Previous studies in mice and humans (Mure et al. 2009; Mure et al. 2007) have 
attributed the ability of a long wavelength red light pulse to enhance responses to subsequent 
blue light exposure to the bistable nature of melanopsin. It has been proposed that, through red 
light stimulation of the M state, the proportion of R state available for subsequent stimulation 
by blue light will be increased resulting in an augmented response. By contrast, concurrent 
presentation of red and blue light, as utilised in the present study, has the theoretical potential 
to both increase and reduce responses observed with blue light alone. The action of red light on 
the pool of M state could either enhance the response by increasing the available proportion of 
‘blue light responsive’ R state or reduce the response by simply attenuating the sustained firing 
of the M state under prolonged exposure to blue light.  In addition, the presence of longer 
wavelength red light could have stimulated the M- and L- cone photoreceptors whose input 
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could have also modulated the response to blue light alone. Indeed, a limitation of the current 
experimental design (and all previous human studies) is that the relative contribution of each 
photoreceptor class cannot be isolated, rather the responses measured result from the aggregate 
input of all three classes of photoreceptors. Increasing evidence suggests that, under specific 
conditions, rods and cones might be important in regulating non-visual responses to light 
(Lucas et al., 2003; Altimus et al., 2010; Lall et al., 2010). Studying patients with retinal 
disorders who lack specific classes of classical photoreceptor may provide information into the 
response dynamics of melanopsin. 
The lack of significant impact of concurrent presentation of red and blue light in the 
current study compared to the observed enhancing effect of consecutive red and blue light for 
the pupil light reflex (PLR) (Mure et al. 2009) may be attributable to differences in the protocol 
such as time of day, light stimulus duration, periods of darkness and dependent variables.  
Firstly the PLR was measured in the morning compared to our nocturnal assessments of 
melatonin suppression; circadian variation in photopigment contribution to non-visual 
responses has been observed previously (Tsai et al. 2009) and could be pertinent here. 
Alternatively, it is possible that, under concurrent red and blue light administration over a 30 
min period, the red light simultaneously enhanced (regenerating R state) and repressed 
(attenuating M state firing) the response to blue light resulting in no overall change in response. 
Thirdly, as the relative sensitivities of the M and R states are unknown, it is possible that the 
irradiances of red light used in the current studies were insufficient to activate the M state 
under constant blue light illumination. Finally, it is possible that regeneration of the R state 
under constant illumination (current study) may be slower than under complete darkness (PLR 
study) such that we observed neither potentiation nor suppression of response.  The dynamics 
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of the photoisomerase (M to R state) function under both light and dark conditions remain to be 
determined. A protocol regime incorporating an extended period of darkness between the red 
and blue light stimuli may be necessary to resolve the photoisomerase function.  
The bistability of melanopsin is an emerging area and it is possible that, in the current 
study, the optimal long wavelength and/or irradiance light, to demonstrate photoisomerase 
activity was not utilised.  Although the in vivo studies of Mure and colleagues (2009; 2007) 
implicated wavelengths > 600 nm (used in the current study), exposure to blue light in 
Amphioxus results in an only slightly red-shifted photoproduct (520 nm) that was then capable 
of photoregenerating the bleached isoform (Koyanagi et al. 2005).  Further complicating the 
interpretation of the present and previous results is the proposed existence of a light-
independent (dark) regeneration mechanism (Koyanagi et al. 2005) as well as the possibility of 
more than one meta-state (Ritter et al. 2004). Melanopsin in dark-adapted mouse retinas has 
been shown to be exclusively bound to 11-cis retinal (Walker et al. 2008) and this apparent 
photo-independent regeneration may have contributed to the results observed by Mure and 
colleagues (Mure et al. 2009; Mure et al. 2007). Thus, regeneration of the R state may be a 
highly complex process and identification of photoisomerase activity may be protocol 
dependent. Finally, the existence of several sub-types of melanopsin ipRGCs which 
differentially innervate different brain areas involved in non-visual responses (Baver et al. 
2008; Ecker et al. 2010) and are themselves differentially reliant upon rod/cone signalling 
(Schmidt and Kofuji 2010) could also contribute to the response diversity observed between 
the PLR (Mure et al. 2009) and the melatonin suppression responses (current study).  
Establishing whether concurrent administration of red light can significantly alter non-
visual responses to blue light is important as this experimental paradigm is likely to be more 
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practical and applicable than the consecutive light pulses used in previous studies (Mure et al. 
2009).  Under the current experimental conditions, there was no evidence of simultaneous red 
light significantly altering non-visual responses to blue light alone.  Future optimisation of 
lighting for health and well-being will require the relative contribution of each photoreceptor 
class to be deciphered as well as the complexities of the melanopsin states to be defined. 
Recent work in transgenic mice lacking rods and cones has demonstrated that the melanopsin 
photosensitivity function alone can predict circadian and pupil responses to a diverse range of 
polychromatic lights (Enezi et al. 2011). These data are in agreement with the current study, 
and whilst not precluding the existence of melanopsin bistability, suggest that the red long 
wavelength content of a light stimulus may not be a significant factor contributing to non-
visual responses to polychromatic light. 
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Figure legends 
 
Figure 1. Plasma melatonin profiles (pg/ml) during and after a 30 min light stimulus (shaded 
area) in 3 participants under no-light control conditions, red (627 nm) monochromatic, blue 
(479 nm) monochromatic and red and blue bichromatic (479 + 627 nm) light. A, Participant 1, 
627: 5 x 1013 photons/cm2/s nm, 479 nm: 5 x 1013 photons/cm2/s, 479 + 627 nm: 1 x 1014 
photons/cm2/s. B, Participant 2, 627 nm: 1 x 1014 photons/cm2/s, 479 nm: 1 x 1014 
photons/cm2/s, 479 + 627 nm: 1.5 x 1014 photons/cm2/s  C, Participant 3, 627 nm: 3 x 1014 
photons/cm2/s, 479 nm: 2.5 x 1013 photon/cm2/s, 479 + 627 nm: 3.3 x 1014 photon/cm2/s. 
 
Figure 2. Percentage melatonin suppression (mean ± SEM) during a 30 min nocturnal red (627 
nm) or blue (479 nm) monochromatic light pulse (shaded area) in the same individuals. A, 5 x 
1013 photons/cm2/s (n = 5). B, 1 x 1014 photons/cm2/s light pulses (n = 4). C, 627 nm (3 x 1014 
photons/cm2/s) and 479 nm (2.5 x 1013 photon/cm2/s) light pulses (n = 8).  
 
Figure 3. Plasma melatonin levels (mean ± SEM; n = 10) before (0 min) and after (30 min) 
monochromatic blue (479 nm) light stimuli of increasing irradiance; the ‘no-light’ control 
condition is indicated by 0.  * p < 0.05; ** p < 0.01, compared to the corresponding 0 min 
condition. 
Figure 4. Percentage melatonin suppression (mean ± SEM) at the end of a 30 min nocturnal 
monochromatic blue light stimulus (λmax 479 nm) alone and in combination with long 
wavelength red light (λmax 627 nm). A, Increasing irradiances of 479 nm light alone and in 
combination with 5 x 1013 photons/cm2/s 627 nm light (n = 10). B, 479 nm (2.5 x 1013 
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photons/cm2/s) light alone and in combination with increasing irradiances of red 627 nm light 
(n = 10).  
 
Figure 5. Subjective alertness levels (mean ± SEM) before, during and after a nocturnal 30 min 
monochromatic or dichromatic light stimulus normalised to 0 min. A, 479 nm light alone at 
three irradiances 1 x 1013 photons/cm2/s  (?), 5 x 1013 photons/cm2/s (?), 1 x 1014 
photons/cm2/s (?), and in combination with fixed 5 x 1013 photons/cm2/s λmax 627 nm light 
resulting in 6 x 1013 photons/cm2/s (?), 1 x 1014 photons/cm2/s (X), and 1.5 x 1014 
photons/cm2/s (?) (n = 10). B, Fixed 2.5 x 10 photons/cm2/s irradiance of blue λmax 479 nm 
light alone (?) and in combination with increasing irradiances of red λmax 627 nm light 
resulting in 7.5 x 1013 photons/cm2/s (?), 1.3 x 1014 photons/cm2/s (?) and 3.3 x 1014 
photons/cm2/s (?) (n = 11).  A significant effect of time but not of light condition was 
observed for both studies. 
